World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
15428
World Ranking
4465
National Ranking
2020

Rebecca S. Gruchalla publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rebecca S. Gruchalla sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 163 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rebecca S. Gruchalla D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rebecca S. Gruchalla sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rebecca S. Gruchalla is affiliated with The University of Texas Southwestern Medical Center in the United States. Their research primarily focuses on the field of Medicine, with specific emphasis on Physiology, Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis, Immunology, and Epidemiology.

The main topics covered by their work include:

  • Asthma and respiratory diseases
  • Respiratory viral infections research
  • Allergic Rhinitis and Sensitization
  • Pediatric health and respiratory diseases
  • IL-33, ST2, and ILC Pathways
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory and Cough-Related Research

They have contributed frequently to the following publication venues:

  • Journal of Allergy and Clinical Immunology (23 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (3 publications)
  • SSRN Electronic Journal (3 publications)
  • The Journal of Allergy and Clinical Immunology In Practice (2 publications)
  • The Lancet (1 publication)

Recent papers authored or co-authored by Rebecca S. Gruchalla include the following:

  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial (2022, The Lancet)
  • Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis (2023, The Lancet Planetary Health)
  • Serum IL-6: A biomarker in childhood asthma? (2020, Journal of Allergy and Clinical Immunology)
  • Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection (2020, American Journal of Respiratory and Critical Care Medicine)
  • Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study (2022, Journal of Allergy and Clinical Immunology)

Some of their frequent co-authors are:

  • Gurjit K. Khurana Hershey
  • Leonard B. Bacharier
  • Daniel J. Jackson
  • Meyer Kattan
  • Edward M. Zoratti

Best Publications

  • Second Symposium on the Definition and Management of Anaphylaxis: Summary Report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium

    Hugh A Sampson;Anne Muñoz-Furlong;Ronna L Campbell;N Franklin Adkinson

  • Results of a Home-Based Environmental Intervention among Urban Children with Asthma

    Wayne J. Morgan;Ellen F. Crain;Rebecca S. Gruchalla;George T. O'Connor

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

    Stanley J Szefler;Herman Mitchell;Christine A Sorkness;Peter J Gergen

  • Symposium on the Definition and Management of Anaphylaxis: Summary report

    Hugh A. Sampson;Anne Muñoz-Furlong;S. Allan Bock;Cara Schmitt

  • Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.

    Stephen J. Teach;Michelle A. Gill;Alkis Togias;Christine A. Sorkness

  • Inner City Asthma Study: Relationships among sensitivity, allergen exposure, and asthma morbidity

    Rebecca S. Gruchalla;Jacqueline A Pongracic;Marshall Plaut;Richard Evans

  • Counterregulation between the FcεRI Pathway and Antiviral Responses in Human Plasmacytoid Dendritic Cells

    Michelle A. Gill;Gagan Bajwa;Tiffany A. George;Caroline C. Dong

  • Acute respiratory health effects of air pollution on children with asthma in US inner cities

    George T. O'Connor;Lucas Neas;Benjamin Vaughn;Meyer Kattan

  • Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.

    Ann Esquivel;William W. Busse;Agustin Calatroni;Alkis G. Togias

  • Clinical Practice. Antibiotic Allergy

    Rebecca S Gruchalla;Munir Pirmohamed

  • Home and allergic characteristics of children with asthma in seven U.S. urban communities and design of an environmental intervention: the Inner-City Asthma Study.

    Ellen F Crain;Michelle Walter;George T. O'Connor;Herman Mitchell

  • Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics.

    Raquel Empedrad;Amy Liebl Darter;Harry S Earl;Rebecca S Gruchalla

  • DNA methylation and childhood asthma in the inner city.

    Ivana V. Yang;Brent S. Pedersen;Andrew Liu;George T. O'Connor

  • Lack of Penicillin Resensitization in Patients With a History of Penicillin Allergy After Receiving Repeated Penicillin Courses

    Roland Solensky;Harry S. Earl;Rebecca S. Gruchalla

  • 10. Drug allergy

    Rebecca S. Gruchalla

  • Airborne fungi in the homes of children with asthma in low-income urban communities: The Inner-City Asthma Study.

    George T. O'Connor;Michelle Walter;Herman Mitchell;Meyer Kattan

  • Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.

    Matthew C Altman;Matthew C Altman;Michelle A Gill;Elizabeth Whalen;Denise C Babineau

  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

    Unknown

  • Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children

    Jacqueline A. Pongracic;George T. O'Connor;Michael L. Muilenberg;Ben Vaughn

  • Asthma phenotypes in inner-city children.

    Edward M. Zoratti;Rebecca Z. Krouse;Denise C. Babineau;Jacqueline A. Pongracic

  • The nasal methylome and childhood atopic asthma

    Ivana V. Yang;Ivana V. Yang;Brent S. Pedersen;Andrew H. Liu;George T. O'Connor

  • Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma

    Meyer Kattan;Sally C. Stearns;Ellen F. Crain;James W. Stout

Frequent Co-Authors

Andrew H. Liu
Andrew H. Liu University of Colorado Denver
William W. Busse
William W. Busse University of Wisconsin–Madison
Jacqueline A. Pongracic
Jacqueline A. Pongracic Lurie Children's Hospital
Peter J. Gergen
Peter J. Gergen National Institute of Allergy and Infectious Diseases
Meyer Kattan
Meyer Kattan Columbia University
Carolyn M. Kercsmar
Carolyn M. Kercsmar Cincinnati Children's Hospital Medical Center
Gurjit K. Khurana Hershey
Gurjit K. Khurana Hershey Cincinnati Children's Hospital Medical Center
Alkis Togias
Alkis Togias National Institute of Allergy and Infectious Diseases
George T. O'Connor
George T. O'Connor Boston University
Agustin Calatroni
Agustin Calatroni Rho Federal Systems (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related degrees such as nursing and healthcare can open diverse career pathways. Many students begin with practical nursing programs that offer accessible entry points; you can find excellent options for lpn schools easy to get into. These programs provide foundational healthcare knowledge applicable to immunology and patient care.

Advancing a nursing career often means pursuing specialized degrees with easier admission requirements. If you’re looking for flexible options, consider nurse practitioner programs with easy admission. These programs help integrate advanced clinical skills, laying the groundwork for specialized roles tied to immune system health.

For those drawn to mental health and immunology's connection with psychiatric conditions, psychiatric-mental health nurse practitioner (PMHNP) programs offer targeted training. Research has shown some of the best psychiatric mental health nurse practitioner programs online also provide strong clinical placements, essential for gaining hands-on experience.

Affordability is a key factor when choosing a program. You can explore affordable pmhnp programs that balance quality education with cost-effective tuition, making career advancement in immunology-adjacent fields more accessible.

Best Scientists Citing Rebecca S. Gruchalla

Trending Scientists

Recently Published Articles